U.S. market
India’s Investment Allure Fades as Capital Shifts to the U.S.
India’s investment landscape is evolving as global funds shift focus to the U.S., raising concerns about future foreign investments.
Sun Pharma Acquires Organon in $11.75 Billion Deal, Shares Surge
Sun Pharma has announced a $11.75 billion acquisition of Organon, boosting its market presence and share value by 5%.